Cabrini Health Limited
Cabrini Health Limited
Malvern, Victoria, Australia4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-05-06 | NCT06819735 | |
| A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, epithelial neoplasm, glioma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, neuroepithelial neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 1 | 2026-04-20 | NCT06326411 | |
| Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309 | Advanced or Metastatic Solid Tumors | Recruiting | Phase 1 | 2025-12-30 | NCT05957081 | |
| HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies | Advanced Solid Tumor Malignancies | Recruiting | Phase 1 / Phase 2 | 2025-01-14 | NCT06649708 |